Abstract
Adolescence has been claimed since the seventies to be associated to a a bad prognosis in childhood ALL. Out of 4658 patients with ALL, 258 adolescents (15–20 year old)(5.5%) were treated in the successive FRALLE 83, FRALLE 87–89, FRALLE 92 (pilot phase), FRALLE 93 and FRALLE 2000 protocols. The main characteristics were: a sex ratio of 1.8 (M/F), a B-lineage in 71% of the cases vs T lineage in 29%, and a median WBC of 12 G/L (9–1000). Translocation and fusion transcripts were searched for in 120 evaluable BCP-ALL: t(9;22)/BCR-ABL, 8 pts (6%); t(1;19)/E2A-PBX1, 12 pts (10%); t(4;11)/MLL-AF4, 4 pts (3%). Out of 75 evaluable pts t(12;21)/TEL-AML1 was found in only 4 pts (3%). 242 out of 258 adolescents were in CR at the end of induction therapy(EOI)(94%) without any significant difference according to the era. Nevertheless a major difference in the 3y and 5y EFS was found:
. | Number of pts . | CR at EOI (%) . | 3y EFS (%) . | 5y EFS (%) . | 10y EFS (%) . |
---|---|---|---|---|---|
*: p=.04; **: p=.04 | |||||
Eighties (F83, F87–89) | 100 | 93 | 42 +/− 5 | 35 +/− 5 | 35 +/− 5 |
Nineties (F92, F93) | 84 | 93 | 71 +/−5* | 67 +/− 5** | 67 +/− 5 |
2000– (F2000) | 74 | 96 | 86 +/−5* | 86 +/− 10** | NYA |
. | Number of pts . | CR at EOI (%) . | 3y EFS (%) . | 5y EFS (%) . | 10y EFS (%) . |
---|---|---|---|---|---|
*: p=.04; **: p=.04 | |||||
Eighties (F83, F87–89) | 100 | 93 | 42 +/− 5 | 35 +/− 5 | 35 +/− 5 |
Nineties (F92, F93) | 84 | 93 | 71 +/−5* | 67 +/− 5** | 67 +/− 5 |
2000– (F2000) | 74 | 96 | 86 +/−5* | 86 +/− 10** | NYA |
The main modification introduced in the nineties was the adoption of a double delayed intensification for the good early responders. Autologous BMT or allogenic BMT were indicated in bad early responders (D8 poor prednisone response, D21 marrow M3 response) and/or unfavourable cytogenetics. The better results of the 2000 protocol can mainly be explained by the further intensification of chemotherapy between induction and delayed Intensification 1 and before delayed Intensification 2. These better results were obtained despite decreasing the indications of BMT (6 performed vs 20 in the nineties) and of CNS irradiation (100% in the nineties vs 35% in the current era, including the TBI for BMTs).
Conclusions:
excellent results can now be achieved in adolescents with ALL
this study emphasizes again the need to treat adolescents with ALL according to pediatric intensive protocols and not “adult-type” protocols, as we recently suggested (Boissel et al, J Clin Oncol 2003).
Whether this could also be applied to young adults remains to be demonstrated but seems appealing.
Disclosure: No relevant conflicts of interest to declare.
Author notes
Corresponding author